Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk

  • Stephan Weidinger
  • , Hansjörg Baurecht
  • , Stefan Wagenpfeil
  • , John Henderson
  • , Natalija Novak
  • , Aileen Sandilands
  • , Huijia Chen
  • , Elke Rodriguez
  • , Grainne M. O'Regan
  • , Rosemarie Watson
  • , Haihui Liao
  • , Yiwei Zhao
  • , Jonathan N.W.N. Barker
  • , Michael Allen
  • , Nick Reynolds
  • , Simon Meggitt
  • , Kate Northstone
  • , George D. Smith
  • , Carolin Strobl
  • , Caroline Stahl
    • Thomas Kneib, Norman Klopp, Thomas Bieber, Heidrun Behrendt, Colin N.A. Palmer, H. Erich Wichmann, Johannes Ring, Thomas Illig, W. H.Irwin McLean, Alan D. Irvine

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Neuroscience

Immunology and Microbiology